Q1 results: Sun Pharma's US business peeps out from clouds

Q1 results: Sun Pharma's US business peeps out from clouds

Sun Pharma’s sales grew sequentially in the June quarter, helped by growth in the US and India. If Sun Pharmaceutical Industries Ltd’s sales in the US turns around, that solves most of its problems. The company’s June quarter (Q1) results did provide a hint of that happening, which was enough to send its shares up […]

Will Sun Pharma get its mojo back on Dalal Street?

Will Sun Pharma get its mojo back on Dalal Street?

ET Intelligence Group: If Sun Pharma’s March quarter performance provided hopes of a possible revival to the Street, the June quarter earnings further cemented it. It is difficult not to be optimistic about Sun Pharma’s prospects, given the recent events. Besides an encouraging quarterly run, the clearance for the Halol facility by USFDA after a […]

Sun Pharma first-quarter profit beats estimates as US sales climb

Sun Pharma first-quarter profit beats estimates as US sales climb

(Reuters) – India’s largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates, helped by stronger sales in the United States. FILE PHOTO: A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai, November 14, 2017. REUTERS/Shailesh Andrade/File Photo Net profit […]

Innovus Pharma Reports New Quarterly Revenue Record of $7.3 million for the Second Quarter 2018 and Expands to …

Innovus Pharma Reports New Quarterly Revenue Record of $7.3 million for the Second Quarter 2018 and Expands to …

SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB: INNV), today reported results for the second quarter 2018. Notable selected highlights from the Second Quarter of 2018 Revenues of $7.3 million, up 259% year-over-year and 61% from prior quarter. Gross margin remains consistent at 81% from prior quarter. Net loss remains consistent at […]

Correvio Pharma Corp. (CORV) CEO Bill Hunter on Q2 2018 Results – Earnings Call Transcript

Correvio Pharma Corp. (CORV) CEO Bill Hunter on Q2 2018 Results – Earnings Call Transcript

Correvio Pharma Corp. (NASDAQ:CORV) Q2 2018 Earnings Conference Call August 14, 2018 4:30 PM ET Executives Bill Hunter – Chief Executive Officer Justin Renz – Chief Financial Office David Dean – Chief Business Development Officer Analysts Dewey Steadman – Canaccord Swayampakula Ramakanth – H.C. Wainwright David Martin – Bloom Burton PJ Solit – Potomac Capital […]

Purdue Pharma sued by New York state

Purdue Pharma sued by New York state

window._taboola = window._taboola || []; _taboola.push({ mode: ‘thumbnails-c’, container: ‘taboola-interstitial-gallery-thumbnails-4’, placement: ‘Interstitial Gallery Thumbnails 4’, target_type: ‘mix’ }); _taboola.push({flush: true}); Photo: Seth Wenig / Associated Press In this July 5, 2018, file photo, New York Gov. Andrew Cuomo speaks at an event in the Brownsville section of Brooklyn, N.Y. New York state has sued […]

India's Sun Pharma quarterly profit beats estimates

India's Sun Pharma quarterly profit beats estimates

Aug 14 (Reuters) – India’s largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates. Net profit came in at 9.83 billion rupees ($140.6 million) for the three months ended June 30, compared with a loss of 4.25 billion rupees a year earlier, the company said here In the year-ago […]

Synergy Pharma: Sales Ramp Ignored

Synergy Pharma: Sales Ramp Ignored

Synergy Pharma (SGYP) has made several rallies towards $2, but the biotech stock hasn’t held any gains despite improving prescription numbers for Trulance that treats IBS. The business developments during the last few months sets the stock up for a sustainable rally. Image Source: Synergy Pharma website Prescription Records My previous research outlined a pattern […]

UroGen Pharma (URGN) CEO Ron Bentsur on Q2 2018 Results – Earnings Call Transcript

UroGen Pharma (URGN) CEO Ron Bentsur on Q2 2018 Results – Earnings Call Transcript

UroGen Pharma (NASDAQ:URGN) Q2 2018 Earnings Conference Call August 14, 2018 8:30 AM ET Executives Catherine Bechtold – Director of Corporate Communications and IR Ron Bentsur – CEO Mark Schoenberg – Chief Medical Officer Stephen Mullennix – COO Analysts Boris Peaker – Cowen Matthew Andrews – Jefferies Leland Gershell – Oppenheimer Reni Benjamin – Raymond […]